SPDR S&P Biotech ETF
709 hedge funds and large institutions have $7.19B invested in SPDR S&P Biotech ETF in 2023 Q1 according to their latest regulatory filings, with 75 funds opening new positions, 227 increasing their positions, 236 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
21% less first-time investments, than exits
New positions opened: 75 | Existing positions closed: 95
26% less funds holding in top 10
Funds holding in top 10: 31 → 23 (-8)
32% less call options, than puts
Call options by funds: $1.15B | Put options by funds: $1.7B
Holders
709
Holding in Top 10
23
Calls
$1.15B
Puts
$1.7B
Top Buyers
| 1 | +$368M | |
| 2 | +$261M | |
| 3 | +$105M | |
| 4 |
Jane Street
New York
|
+$88.5M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$78.4M |
Top Sellers
| 1 | -$221M | |
| 2 | -$93.4M | |
| 3 | -$74.5M | |
| 4 |
CI
Clal Insurance
Tel-Aviv,
Israel
|
-$69.6M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$63.6M |